ID   LANCEi020-A-6
SY   iPS-16-FBN1-HI3; IPSC16-FBN1-HI3
DR   hPSCreg; LANCEi020-A-6
DR   Wikidata; Q108820662
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Knockout cell: Method=CRISPR/Cas9 (1 of 2 alleles); HGNC; 3601; FBN1.
CC   Derived from sampling site: Peripheral blood.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 16-12-21; Version: 2
RX   PubMed=34174776; DOI=10.1016/j.scr.2021.102434;
RA   Borsoi J., Farinha-Arcieri L.E., Morato-Marques M., Sarafian R.D.,
RA   Pinheiro M., Pereira L.V.;
RT   "Generation of genetically modified human induced pluripotent stem
RT   cell lines harboring haploin sufficient or dominant negative variants
RT   in the FBN1 gene.";
RL   Stem Cell Res. 54:102434-102434(2021).